Fundraising Fox

Amyris

Emeryville, US · Delaware corporation · 994 employees on LinkedIn · 3 known investors

Amyris develops a biomanufacturing platform that uses fermentation and microbial engineering to produce natural ingredients and rare compounds at scale for partners across industries such as specialty chemicals, food ingredients, and consumer products. Founded in 2003, the company focuses on sustainable, bio-based sourcing of molecules.

Advanced Manufacturing Biotech Cleantech New Materials

Founders & leadership

NK

NICHOLAS KHADDERSenior Vice President, General Counsel & Secretaryformer

RA

RAFFI ASADORIAN

RAFFI ASADORIANinCFO2015–2017

JC

Joel Cherry

Joel CherryinPresident, R&D2008–2019

TT

Tamara Tompkins

Tamara TompkinsinExecutive Vice President & General Counsel2005–2012Executive Officer at Neumora Therapeutics

JM

John Melo

John MeloinPresident & Chief Executive Officer2007–2023

PD

Paulo Diniz

Paulo DinizinCFO Global | CEO Brazil2011–2015

JH

Jeryl HillemanChief Financial Officerformer

Board

JD

John Doerr

John Doerr in 𝕏Board directorChairman of Kleiner Perkins

FR

FERNANDO REINACHBoard directorformer

PB

PHILIPPE BOISSEAUBoard directorformer

SA

SHEIK ABDULLAH BIN KHALIFA AL THANIBoard directorformer

GD

GEOFFREY DUYKBoard directorformer

Investors · 3

Kleiner PerkinsMenlo Park · $500K – $15Mvia John Doerr · board

R7 PartnersChicago · $100K – $5M

Vivo CapitalreportedPalo Alto · $10M – $50Mvia Frank Kung · board

Reported raises · per SEC filings

Form D private placements

$1.3B disclosed across 38 rounds · 2012–2022

▶$8MraisedSep 2022 · 1 investors · Manufacturing

Rule 506(b)

Officers, directors & promoters on the filing

NICOLE KELSEYExecutive Officer
HERMANUS KIEFTENBELDExecutive Officer
EDUARDO ALVAREZExecutive Officer
JOHN MELOExecutive Officer, Director
FRANK KUNGDirector
LISA QIDirector
JULIE WASHINGTONDirector
PHILIP EYKERMANDirector
GEOFFREY DUYKDirector
RYAN PANCHADSARAMDirector
ANA DUTRADirector
JAMES MCCANNDirector
STEVEN MILLSDirector
L JOHN DOERRDirector

Offering amount: $8M
Amount sold: $8M
First sale: Sep 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$200MraisedJun 2020 · 53 investors · Manufacturing

Rule 506(b)

Officers, directors & promoters on the filing

JAMES MCCANNDirector
STEVEN MILLSDirector
GEOFFREY DUYKDirector
LISA QIDirector
PHILIP EYKERMANDirector
JOHN MELOExecutive Officer, Director
L JOHN DOERRDirector
NICOLE KELSEYExecutive Officer
CHRISTOPH GOPPELSROEDERDirector
EDUARDO ALVAREZExecutive Officer
CAROLE PIWNICADirector
HAN KEIFTENBELDExecutive Officer
FRANK KUNGDirector
PATRICK YANGDirector

Offering amount: $200M
Amount sold: $200M
Sales commissions: $9M
Placement agents: JEFFERIES LLC, COWEN AND COMPANY, LLC, OPPENHEIMER & CO. INC.
First sale: Jun 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$93.7MraisedFeb 2020 · 7 investors · Manufacturing

Rule 506(b)

Officers, directors & promoters on the filing

JOHN MELOExecutive Officer, Director
EDUARDO ALVAREZExecutive Officer
NICOLE KELSEYExecutive Officer
KATHLEEN VALIASEKExecutive Officer
L JOHN DOERRDirector
GEOFFREY DUYKDirector
PHILIP EYKERMANDirector
CHRISTOPH GOPPELSROEDERDirector
FRANK KUNGDirector
CAROLE PIWNICADirector
STEVEN MILLSDirector
R NEIL WILLIAMSDirector
PATRICK YANGDirector
JONATHAN WOLTERExecutive Officer
JAMES MCCANNDirector
LISA QIDirector

Offering amount: $93.7M
Amount sold: $93.7M
First sale: Jan 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$9.8MraisedJan 2020 · 4 investors · Manufacturing

Rule 506(b)

Officers, directors & promoters on the filing

CAROLE PIWNICADirector
STEVEN MILLSDirector
R NEIL WILLIAMSDirector
PATRICK YANGDirector
JONATHAN WOLTERExecutive Officer
LISA QIDirector
FRANK KUNGDirector
CHRISTOPH GOPPELSROEDERDirector
L JOHN DOERRDirector
GEOFFREY DUYKDirector
PHILIP EYKERMANDirector
JAMES MCCANNDirector
JOHN MELOExecutive Officer, Director
EDUARDO ALVAREZExecutive Officer
NICOLE KELSEYExecutive Officer
KATHLEEN VALIASEKExecutive Officer

Offering amount: $9.8M
Amount sold: $9.8M
First sale: Jan 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$3.9MraisedDec 2019 · 1 investors · Manufacturing

Rule 506(b)

Officers, directors & promoters on the filing

JOHN MELOExecutive Officer, Director
GEOFFREY DUYKDirector
LISA QIDirector
JAMES MCCANNDirector
JONATHAN WOLTERExecutive Officer
PATRICK YANGDirector
R NEIL WILLIAMSDirector
STEVEN MILLSDirector
CAROLE PIWNICADirector
FRANK KUNGDirector
CHRISTOPH GOPPELSROEDERDirector
PHILIP EYKERMANDirector
L JOHN DOERRDirector
KATHLEEN VALIASEKExecutive Officer
NICOLE KELSEYExecutive Officer
EDUARDO ALVAREZExecutive Officer

Offering amount: $3.9M
Amount sold: $3.9M
First sale: Nov 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$7.8MraisedNov 2019 · 2 investors · Manufacturing

Rule 506(b)

Officers, directors & promoters on the filing

JAMES MCCANNDirector
LISA QIDirector
JOHN MELOExecutive Officer, Director
EDUARDO ALVAREZExecutive Officer
NICOLE KELSEYExecutive Officer
KATHLEEN VALIASEKExecutive Officer
L JOHN DOERRDirector
GEOFFREY DUYKDirector
PHILIP EYKERMANDirector
CHRISTOPH GOPPELSROEDERDirector
FRANK KUNGDirector
CAROLE PIWNICADirector
STEVEN MILLSDirector
R NEIL WILLIAMSDirector
PATRICK YANGDirector
JONATHAN WOLTERExecutive Officer

Offering amount: $7.8M
Amount sold: $7.8M
First sale: Nov 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$7.7MraisedNov 2019 · 1 investors · Manufacturing

Rule 506(b)

Officers, directors & promoters on the filing

JAMES MCCANNDirector
LISA QIDirector
EDUARDO ALVAREZExecutive Officer
JOHN MELOExecutive Officer, Director
JONATHAN WOLTERExecutive Officer
PATRICK YANGDirector
R NEIL WILLIAMSDirector
STEVEN MILLSDirector
CAROLE PIWNICADirector
FRANK KUNGDirector
CHRISTOPH GOPPELSROEDERDirector
NICOLE KELSEYExecutive Officer
GEOFFREY DUYKDirector
PHILIP EYKERMANDirector
KATHLEEN VALIASEKExecutive Officer
L JOHN DOERRDirector

Offering amount: $7.7M
Amount sold: $7.7M
First sale: Oct 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.7MraisedOct 2019 · 1 investors · Manufacturing

Rule 506(b)

Officers, directors & promoters on the filing

L JOHN DOERRDirector
GEOFFREY DUYKDirector
PHILIP EYKERMANDirector
CHRISTOPH GOPPELSROEDERDirector
FRANK KUNGDirector
JOHN MELOExecutive Officer, Director
EDUARDO ALVAREZExecutive Officer
KATHLEEN VALIASEKExecutive Officer
NICOLE KELSEYExecutive Officer
LISA QIDirector
CAROLE PIWNICADirector
STEVEN MILLSDirector
R NEIL WILLIAMSDirector
PATRICK YANGDirector
JONATHAN WOLTERExecutive Officer
JAMES MCCANNDirector

Offering amount: $5.7M
Amount sold: $5.7M
First sale: Oct 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

The Amyris mafia →

6 people who came through Amyris went on to found or lead other companies.

Frances H. ArnoldScience AdvisorFounded Provivi Thomas YbertMetabolic Engineering Project LeaderFounded Dnascript Jeff KimProject Lead (Jet Fuel Development)Founded Slingshot Biosciences Kristy HawkinsScientistFounded Antheia, Inc.Gloria LinStrategy & Planning InternFounded Siteline Jason RyderDirector, Process EngineeringFounded Oobli

Competitors · 2

by search overlap

Alumis19 shared keywordsAlumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted therapies for immune-mediated diseases. It focuses on small-molecule drug discovery and development in immunology and inflammation.

Fortis Life Sciences11 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.

Companies competing with Amyris for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Amyris: $1.15B Debt Cut as Consumer Brands Were Sold in Chapter 11elevenflo.com · Mar 2026

Who Owns Amyris Company? – MatrixBCG.commatrixbcg.com · Mar 2026

AMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDINGprnewswire.com · Jun 2023

Amyris Raises $200 Million From Private Placement | PR Newswire | wfmz.comwfmz.com · Jun 2020

Amyris Biotechnologies Raises $47.8M - FinSMEsfinsmes.com · Apr 2010

Frequently asked questions

What does Amyris do?: Amyris develops a biomanufacturing platform that uses fermentation and microbial engineering to produce natural ingredients and rare compounds at scale for partners across industries such as specialty chemicals, food ingredients, and consumer products. Founded in 2003, the company focuses on sustainable, bio-based sourcing of molecules.
Who are Amyris's investors?: Amyris's investors include Kleiner Perkins, R7 Partners, Vivo Capital.
How much funding has Amyris raised?: Amyris has disclosed $1.3B raised across 38 rounds.
Where is Amyris headquartered?: Amyris is headquartered in Emeryville, US.